Literature DB >> 169279

A radioreceptor assay for evaluation of the plasma glucocorticoid activity of natural and synthetic steroids in man.

P L Ballard, J P Carter, B S Graham, J D Baxter.   

Abstract

An assay for plasma glucocorticoid activity has been developed using specific glucocorticoid receptors. Unlike other assays for cortisol and certain synthetic corticosteroids, this radioreceptor assay measures the glucocorticoid activity of all natural an synthetic steroids. Steroids extracted from as little as 0.05 ml of plasma are incubated with 3H-dexamethasone and cytosol receptors from cultured rat hepatome cells. From 0.5 to 50 ng of cortisol are accurately detected. Glucocorticoid activities of adult determined by the assay correlate closely with corticoid levels obtained in the CBG-isotope and fluorometric assays. Other steroids are measured in proportion to both concentration and potency as glucocorticoids. Relative activities include: cortisol 100, dexamethasone 940, prednisolone 230, prednisone 3, estradiol 1 and androstenedione 1. A similar ranking of steroids was found using receptors from a human source (fetal lung). The assay has been useful in detecting glucocorticoid activity in unidentified medications and in measuring plasma glucocorticoid levels after administration of synthetic corticosteroids. A modification of the assay is described for also estimating the level of free (unbound) glucocorticoid activity in plasma. Assays are performed before and after removal by charcoal of steroids not bound to plasma transcortin. This consideration is shown to be particularly important with prednisolone where the unbound steroid level is much less than the total. Thus, the radioreceptor assay provides a relatively simple technique for measuring the total of free plasma of glucocorticoid activity in man due to any natural or synthetic steroid or combination of steroids.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169279     DOI: 10.1210/jcem-41-2-290

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Inhaled budesonide regimen enhances serotonin- and arachidonic acid-induced platelet aggregation.

Authors:  L Hasselmark; R Malmgren; A Dumitrescu
Journal:  Agents Actions       Date:  1992-05

2.  Dose-dependent pharmacokinetics of dexamethasone.

Authors:  D Loew; O Schuster; E H Graul
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  Concurrent administration of antacids and prednisone: effect on serum levels of prednisolone.

Authors:  A R Tanner; J A Caffin; J W Halliday; L W Powell
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

Review 4.  Corticosteroids in liver disease: possible mechanisms of action, pharmacology, and rational use.

Authors:  A R Tanner; L W Powell
Journal:  Gut       Date:  1979-12       Impact factor: 23.059

5.  Relative glucocorticoid potency revisited.

Authors:  H Tanaka; F Hirano; Y Nomura; T Miura; Y Makino; E Fukawa; I Makino
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

6.  Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome.

Authors:  P L Ballard; P Granberg; R A Ballard
Journal:  J Clin Invest       Date:  1975-12       Impact factor: 14.808

7.  Influence of glucocorticoids on histamine release and 45calcium uptake by isolated rat mast cells.

Authors:  N Grosman; S M Jensen
Journal:  Agents Actions       Date:  1984-01

8.  The effects of different steroids on costal and epiphyseal cartilage of fetal and adult rats.

Authors:  L C Dearden; H D Mosier; M Brundage; C Thai; R Jansons
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

9.  Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.

Authors:  J D Baxter; M Schambelan; D T Matulich; B J Spindler; A A Taylor; F C Bartter
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

10.  A comparison of the bioavailability and potency of dexamethasone phosphate and sulphate in man.

Authors:  S Miyabo; T Nakamura; S Kuwazima; S Kishida
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.